Literature DB >> 11727160

[Highly resistant pathogens in patients with diabetic foot syndrome with special reference to methicillin-resistant Staphylococcus aureus infections].

A Wagner1, H Reike, B Angelkort.   

Abstract

BACKGROUND AND
OBJECTIVE: Patients with diabetic foot infection (DFI) have a high rate of infection, up to 40%, with methicillin-resistant Staph. aureus (MRSA). Having noticed a definite increase of such patients in our special unit, we initiated a drastic change of hygienic measures and here report the results. PATIENTS AND METHODS: 788 patients with DFI (mean age 67.3 [32-90] years, 62% males) were admitted between 1.1.1999 and 31.7.2000. Before 31.7.1999, the following hygienic measures had been in place: cohort isolation, protective closing, implementation of general hygienic rules. Since 1.8.1999, modified measures have been undertaken: primary single-patient isolation, concentration in one ward of all patients with MRSA, medical care only by trained personnel, admission of patients only after microbiological results were known or primary solitary isolation. Algorithms were used for the transmission of all necessary information.
RESULTS: MRSA was demonstrated in 64 patients. The number of infections during the hospital stay, before and after the change of hygienic measures were 9 (27%) and 2 patients (8%), respectively. The sites of MRSA colonisation and proven eradication were: nasopharynx only, 3 with 67% eradication; MRSA in a wound, 25 with 28% eradication. In comparison to the yearly statistic on wound healing in DFI 1999 (n=613) the following results are shown (patients with MRSA in brackets): healing rate with conservative treatment 61.5% (20%), minor-amputation 30.5% (52%), major-amputation 4.5% (22%), death 3.5% (6%).
CONCLUSIONS: The rate of new infections were dramatically reduced by changing the hygienic measures. The rate of successful sanitation was unsatisfactoy. Patients with MRSA showed markedly poorer treatment results in respect to wound healing.

Entities:  

Mesh:

Year:  2001        PMID: 11727160     DOI: 10.1055/s-2001-18655

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  11 in total

Review 1.  Diabetic foot infections: stepwise medical and surgical management.

Authors:  David G Armstrong; Benjamin A Lipsky
Journal:  Int Wound J       Date:  2004-06       Impact factor: 3.315

2.  Ceftobiprole: First reported experience in osteomyelitis.

Authors:  A Macdonald; G Dow
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  Vacuum-assisted closure instill as a method of sterilizing massive venous stasis wounds prior to split thickness skin graft placement.

Authors:  Wissam Raad; John C Lantis; Leslie Tyrie; Cynthia Gendics; George Todd
Journal:  Int Wound J       Date:  2010-04       Impact factor: 3.315

4.  Optimal management of uncomplicated skin and skin structure infections of the lower extremity.

Authors:  Warren S Joseph
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

5.  Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost.

Authors:  B A Lipsky; Y P Tabak; R S Johannes; L Vo; L Hyde; J A Weigelt
Journal:  Diabetologia       Date:  2010-02-10       Impact factor: 10.122

Review 6.  Methicillin-resistant Staphylococcus aureus in diabetic foot infections.

Authors:  Ioanna Eleftheriadou; Nicholas Tentolouris; Vasiliki Argiana; Edward Jude; Andrew J Boulton
Journal:  Drugs       Date:  2010-10-01       Impact factor: 9.546

7.  New insights in diabetic foot infection.

Authors:  Jean-Louis Richard; Albert Sotto; Jean-Philippe Lavigne
Journal:  World J Diabetes       Date:  2011-02-15

8.  A prospective, multi-center study: factors related to the management of diabetic foot infections.

Authors:  B M Ertugrul; O Oncul; N Tulek; A Willke; S Sacar; O G Tunccan; E Yilmaz; O Kaya; B Ozturk; O Turhan; N Yapar; M Ture; F Akin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-22       Impact factor: 3.267

9.  Management of diabetic foot infections in an era of increasing microbial resistance.

Authors:  Sandra Bliss Nelson
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

10.  [Principles of treatment for deep infections of the diabetic foot].

Authors:  S Kessler; P Delhey; C Volkering
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.